Thursday, August 16, 2018
 
 
Company News: Page (1) of 1 - 08/05/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Fetal Bovine Serum Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

(August 05, 2018)
"Global Fetal Bovine Serum Industry"
The global Fetal Bovine Serum (FBS) market is projected to witness a growth rate of 6.8% during the forecast period (2018-2023).

Global Fetal Bovine Serum Industry

New Study On “2018-2023 Fetal Bovine Serum Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The global Fetal Bovine Serum (FBS) market is projected to witness a growth rate of 6.8% during the forecast period (2018-2023). Rising stem cell therapy as cell culture and development of cells in artificial environment in biopharma and biotech are the key motivators of the FBS market. The availability of FBS is reducing and the production cost is increasing as the market is experiencing unprecedented dynamics such as mergers and divestitures, raw material shortages, and product recalls. Biopharma applications such as newborn calf serum and donor bovine serum for animal health vaccine such as bovine, equine, caprine, porcine, and lapine are gaining popularity towards the development of global FBS market.

FBS is the most commonly used supplement in animal cell culture media. Cell cultures have many clinical applications in medicine, such as the production of vaccines, diagnostic tests, and cell therapy. FBS used in cell cultures contain more growth factors than other animal serum media and has the advantage of very low levels of antibodies. On the other hand, it has the disadvantage of high costs and the need for testing and the elimination of adventitious viruses, as do other media of animal origin. The cattle diseases of concern for FBS are those, which cross the placental barrier of the cow and infect the calf fetus, thus contaminating FBS and making it unsuitable for use in cell cultures. However, diagnostic labs, pharmaceutical companies, and many researchers still depend on FBS heavily to fulfill their cell culture needs.



Try Sample Report @ https://www.wiseguyreports.com/sample-request/3186955-global-fetal-bovine-serum-market-research-and-forecast-2018-2023

In the present times, there are many types of FBS, which are used for special biochemical and hormonal tests, and bacterial tests suited for immunological testing. Invitrogen developed an iMatch tool specialized in finding variability in FBS and providing high grade and scale serum that can further be used in biotechnology and biopharma research works. The machine can provide testing such as determine plating efficiency, heat inactivation, gamma irradiation and reserve serum testing for customized serum base applications.

The global FBS market has three foremost cell culture protein segments, including animal derived protein, human derived protein, and synthetic protein. The animal derived protein havs significant usage in applied research such as drug development and cell structure analysis, while the human derived protein, which is collected from human blood is reliable and useful in many research studies as in developmental research such as cell-based therapeutics, tissue engineering, and drugs and vaccines development. The synthetic protein provides more efficient and reproducible results in R&D, biotechnology and adaption of advanced technology in genome engineering for synthetic biology.

The global FBS market can also be bifurcated on the basis of geography including North America, Asia Pacific, Europe and Rest of the World. The report basically covers FBS market in North America, South America, Europe, the Middle East and Africa, and APAC regions. The US being the biggest market for FBS, and North America and Australia are major suppliers for FBS, they likely to be used in scientific research, cell cultivation and development of new vaccines. Some of the key players present within North America are Atlas Biologicals, FB Sciences, and Innovative Research. Europe after North America and Australia is a significant supplier of FBS due to its adequate demand and supply chain model among Germany, Italy, Spain, and the U.K. Asia-Pacific is expected to show continual growth owing to low labor cost, less capital investment for manufacturing of fetal bovine serum, rising demand for Australia origin fetal bovine serum, and increasing cell maintenance banks, and specialty research institutes. China is the leading country with high amount of cow slaughter for FBS extraction for use in local research and development within the country. Due to rise in cell cultivation and stem cell therapy, there is significant rise in the demand in Japan for FBS but due to low deficiency of fetal bovine blood, the end users of Japan like, Eil, Riken and Reddit Health are importing the raw material FBS from Australia or New Zealand as the serum originated from these countries is higher in grade as well as in price as that of the US.

The global FBS market is dynamic in nature due to the presence of a large number of market players and rigorous supply and demand. Key market players of the global FBS market include Thermo-Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate Biotech, Tissue Culture Biologicals, Bovogen Biologicals, and Corning Inc. The key strategies adopted by the market players for strengthening their market share in global FBS market includes mergers & acquisitions, development of innovative serum technology, contracts & agreements, and geographical expansions.

In 2015, the Life Science Cluster Switzerland developed innovative FBS Gold Serum, produced by chemically separating the proteins, which are not synthetically produced to have same grades of standard as of FBS and is priced competitively. As FBS prices started to escalate, RMBio prioritized sourcing the highest quality newborn calf serum, resulting in an alternative FBS technique that falls within FBS specifications for hemoglobin and endotoxin, while total protein ranges from 4.9 to 5.7, which is outside FBS specification of <4.5. It is going to take a while to get the market back in balance, thus any significant price relief on FBS will take some time to develop. With so many factors weighing on the FBS supply and demand, it is more of an art than a science to gauge the market sentiment and direction.

The report covers:

Comprehensive research methodology of Global Fetal Bovine Serum market 
In-depth analysis of macro and micro factors influencing the market guided by key recommendations. 
Analysis of regional regulations and other government policies impacting the Global Fetal Bovine Serum market 
Insights about market determinants which are stimulating the Global Fetal Bovine Serum market 
Detailed and extensive market segments with regional distribution of researched revenues 
Extensive profiles and recent developments of market players 

For Detailed Reading Please visit WiseGuy Reports @     https://www.wiseguyreports.com/reports/3186955-global-fetal-bovine-serum-market-research-and-forecast-2018-2023

Some Major Points from Table of content:

1. REPORT SUMMARY 
1. RESEARCH METHODS AND TOOLS 
1.2. MARKET BREAKDOWN 
1.2.1. BY SEGMENTS 
1.2.2. BY GEOGRAPHY 
1.2.3. BY STAKEHOLDERS 
1.2.3.1. RAW MATERIAL SUPPLIERS 
1.2.3.2. MANUFACTURERS 
1.2.3.3. DISTRIBUTORS 
2. MARKET OVERVIEW AND INSIGHTS 
2.1. DEFINITION 
2.2. ANALYST & CURRENT MARKET TRENDS 
2.2.1. KEY FINDINGS 
2.2.2. RECOMMENDATION 
2.2.3. CONCLUSION 
2.3. REGULATIONS 
2.3.1. UNITED STATES 
2.3.2. EUROPEAN UNION 
2.3.3. CHINA 
2.3.4. INDIA 
2.3.5. REST OF THE WORLD 
2.4. PATENT ANALYSIS 
3. MARKET DETERMINANT 
3.1. MOTIVATORS 
3.1.1. CRITICAL RAW MATERIAL FOR BIOTECHNOLOGY, AND THE PHARMACEUTICAL INDUSTRY 
3.1.2. FBS IS THE MOST COMMONLY USED SUPPLEMENT IN ANIMAL CELL CULTURE SUCH AS VACCINES, DIAGNOSTIC TESTS AND CELL THERAPY 
3.1.3. USEFUL IN PRODUCTION OF PROTIEN AND CELLS FOR MEDICAL PURPOSES 
3.1.4. HELPS INCREASING CHLOROPHYLL CONTENT, PHYTOTOXICITY, NUTRIENT CONTENTS AND FERTILIZER EFFICIENCY 
3.2. RESTRAINTS 
3.2.1. COST OF FBS INCREASED EXPONENTIALLY AS ENVIRONMENTAL CONDITIONS DETERIORATED 
3.2.2. GOVERNMENT REGULATIONS OBSTRUCTING IMPORT & EXPORT OF FBS 
3.2.3. RISE IN CATTLE DISEASES CONTAMINATING CALF FETUS MAKING FBS UNUSABLE 
3.3. OPPORTUNITIES 
3.3.1. FBS MAJOR INGREDIENT FOR NUTRIENT MEDIUM IN LARGE VOLUMES. 
3.3.2. SWAYING MARKET TREND FROM ANIMAL DERIVATIVES TO HUMAN SERUM FOR NEW CELL LINE 
3.3.3. RISE IN SCOPE OF APPLICATIONS IN PRODUCTION OF DRUGS, TOXICITY TESTING AND SO ON ALSO HELPFUL IN VITRO FERTILIZATION 
4. MARKET SEGMENTATION 
4.1. FETAL BOVINE SERUM MARKET BY PRODUCT TYPE 
4.1.1. CHARCOAL STRIPPED 
4.1.2. CHROMATOGRAPHIC 
4.1.3. DIALYZED FBS 
4.1.4. EXOSOME DEPLETED 
4.1.5. STEM CELL 
4.1.5.1. EMBRYONIC STEM CELLS QUALIFIED 
4.1.5.2. MESENCHYMAL STEM CELL QUALIFIED 
4.1.6. OTHERS 
4.2. FETAL BOVINE SERUM MARKET BY END USER 
4.2.1. ACADEMIC INSTITUTES 
4.2.2. DIAGNOSTIC LABS 
4.2.3. CELL BANKS 
4.2.4. BIOPHARMACEUTICAL COMPANIES 
4.3. FETAL BOVINE SERUM MARKET BY APPLICATIONS 
4.3.1. INDUSTRIAL RESEARCH 
4.3.1.1. ANTIBODY PRODUCTION 
4.3.1.2. VETENARY APPLICATIONS 
4.3.2. SCIENTIFIC RESEARCH 
4.3.2.1. CELL CULTURE MAINTENANCE 
4.3.2.2. EXOSOME RESEARCH 
4.3.2.3. IMMUNOASSAYS METHODS 
4.3.2.3.1. RADIOLABELLING ASSAYS METHOD 
4.3.2.3.2. INSULIN ASSAY METHOD 
4.3.3. OTHERS 
5. COMPETITIVE LANDSCAPE 
5.1. KEY MARKET STRATEGY ANALYSIS 
5.2. KEY COMPANY ANALYSIS 
6. REGIONAL ANALYSIS 
6.1. NORTH AMERICA 
6.1.1. UNITED STATES 
6.1.2. CANADA 
6.1.3. REST OF NORTH AMERICA 
6.2. EUROPE 
6.2.1. UNITED KINGDOM 
6.2.2. FRANCE 
6.2.3. GERMANY 
6.2.4. ITALY 
6.2.5. SPAIN 
6.2.6. REST OF EUROPE 
6.3. ASIA PACIFIC 
6.3.1. INDIA 
6.3.2. CHINA 
6.3.3. JAPAN 
6.3.4. REST OF ASIA PACIFIC 
6.4. REST OF THE WORLD 

Continued…..

For more information or any query mail at [email protected]

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

 

 

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: [email protected]
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3186955-global-fetal-bovine-serum-market-research-and-forecast-2018-2023



Source: www.abnewswire.com


Page: 1


Related Keywords:Health & Medicine,Hospitality,Pharmaceuticals & Biotech,Science,Technology,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • Wearable Medical Devices Global Market Opportunities And Strategies To 2022
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  • ViewRay Announces Pricing of Public Offering of Common Stock
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines